New analysis of Gazyva® shows the drug significantly reduces disease activity in adults with systemic lupus erythematosus.

Cutaneous lupus erythematosus is a chronic autoimmune disease with few treatment options and no approved targeted therapies.

Lupus treatment is different for different people. That’s because no two cases of lupus are the same — each person experiences lupus differently. That’s why it’s so important to work closely with your ...

Phase 3 trial data show that obinutuzumab significantly reduces disease activity in very active extrarenal lupus.

More than three-quarters of lupus patients taking obinutuzumab (Gazvya) had a significant improvement in their symptoms after a year on the drug, researchers reported March 6 in The New England ...

Johnson & Johnson's nipocalimab has been granted U.S. Food and Drug Administration Fast Track designation as a potential ...

SEEING RESULTS. HERE’S NICOLE. IT’S A MARVEL OF BIOLOGICAL ENGINEERING. FOR 30 YEARS, DOCTOR ROBERTO CARRICO, A RHEUMATOLOGIST AT UMASS CHAN MEDICAL SCHOOL, AND HIS PATIENTS HAVE BEEN FIGHTING AN ...

People with lupus often need to use medicines to manage their symptoms. Although there are many oral medicines that treat lupus, some people with more severe symptoms may not get enough benefit from ...

CNIs are also playing an increasingly visible role in treatment strategies. About one in five LN patients managed by nephrologists, and slightly more among rheumatologists, are currently receiving a ...

Lupus is more common in Black people, and symptoms can be different too. Here's what to look out for and how to treat it.

Early diagnosis of lupus is important, so that treatment to prevent irreversible organ damage can begin. In this national registry study, lupus diagnosis was preceded by years of markedly increased ...

Hidradenitis suppurativa (HS) and lupus are distinct conditions that share some features, including immune system dysregulation and chronic inflammation. A person can have one or both of these ...